Product Information
CLINDAMYC-BNZ PEROX 1.2-3.75% is a generic product labeled by Oceanside Pharmaceuticals, priced at $3.6862 per GM under NDC 68682013350. Its NADAC has been published 90 times since Jan 17, 2024.
FDA first approved this application on Oct 23, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
37.5; 10 mg/g; mg/g
Manufacturer
Oceanside PharmaceuticalsNDC
68682013350
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA050819FDA Approved
10/23/2008
TE Code
AB
On Market Since
10/2/2023
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has been published 90 times since Jan 17, 2024, and over the history we have for it it has declined 39.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6862 per GM |
|---|---|
| All-time high | $7.6354 (Apr 10, 2024) |
| All-time low | $3.6862 (Sep 17, 2025) |
| 52-week high | $3.7712 |
| 52-week low | $3.6862 |
| Median price | $4.7057 |
| Average price | $4.9152 |
| Largest weekly change | -45.1% (Apr 17, 2024) |
| Weeks tracked | 90 |
| Tracking since | Jan 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-2.3%
3Y
N/A
5Y
N/A
All
-39.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDAMYC-BNZ PEROX 1.2-3.75%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYC-BNZ PEROX 1.2-3.75%, manufactured by Oceanside Pharmaceuticals, is $3.6862 per GM (NDC 68682013350), effective Oct 1, 2025.
How has the price of CLINDAMYC-BNZ PEROX 1.2-3.75% changed over time?
Over the history we have for it, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has declined 39.3%. It has been tracked across 90 weekly CMS publications since Jan 17, 2024.
What are the highest and lowest recorded NADAC prices for CLINDAMYC-BNZ PEROX 1.2-3.75%?
Since Jan 17, 2024, the NADAC for CLINDAMYC-BNZ PEROX 1.2-3.75% has ranged from a low of $3.6862 (Sep 17, 2025) to a high of $7.6354 (Apr 10, 2024), with a median of $4.7057 per GM.
Are there cheaper alternatives to CLINDAMYC-BNZ PEROX 1.2-3.75%?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYC-BNZ PEROX 1.2-3.75%, is $2.4723 per GM — about 33% below CLINDAMYC-BNZ PEROX 1.2-3.75%.
Who manufactures CLINDAMYC-BNZ PEROX 1.2-3.75%?
CLINDAMYC-BNZ PEROX 1.2-3.75% (NDC 68682013350) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.